A Phase I Study of Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer
Latest Information Update: 16 Jul 2023
At a glance
- Drugs Lapatinib (Primary) ; Trastuzumab
- Indications Advanced breast cancer; Brain metastases; HER2 positive breast cancer
- Focus Adverse reactions
- 03 Dec 2013 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 11 Sep 2012 Planned end date changed from 1 Jan 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 19 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.